756 related articles for article (PubMed ID: 16721394)
1. Dose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.
Larsen CN; Nielsen S; Kaestel P; Brockmann E; Bennedsen M; Christensen HR; Eskesen DC; Jacobsen BL; Michaelsen KF
Eur J Clin Nutr; 2006 Nov; 60(11):1284-93. PubMed ID: 16721394
[TBL] [Abstract][Full Text] [Related]
2. Immunomodulating potential of supplementation with probiotics: a dose-response study in healthy young adults.
Christensen HR; Larsen CN; Kaestel P; Rosholm LB; Sternberg C; Michaelsen KF; Frøkiaer H
FEMS Immunol Med Microbiol; 2006 Aug; 47(3):380-90. PubMed ID: 16872374
[TBL] [Abstract][Full Text] [Related]
3. Lactobacillus acidophilus 74-2 and Bifidobacterium animalis subsp lactis DGCC 420 modulate unspecific cellular immune response in healthy adults.
Klein A; Friedrich U; Vogelsang H; Jahreis G
Eur J Clin Nutr; 2008 May; 62(5):584-93. PubMed ID: 17440520
[TBL] [Abstract][Full Text] [Related]
4. Impact of consumption of different levels of Bifidobacterium lactis HN019 on the intestinal microflora of elderly human subjects.
Ahmed M; Prasad J; Gill H; Stevenson L; Gopal P
J Nutr Health Aging; 2007; 11(1):26-31. PubMed ID: 17315077
[TBL] [Abstract][Full Text] [Related]
5. The immune system in healthy adults and patients with atopic dermatitis seems to be affected differently by a probiotic intervention.
Roessler A; Friedrich U; Vogelsang H; Bauer A; Kaatz M; Hipler UC; Schmidt I; Jahreis G
Clin Exp Allergy; 2008 Jan; 38(1):93-102. PubMed ID: 18028460
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the immune benefits of two probiotic strains Bifidobacterium animalis ssp. lactis, BB-12® and Lactobacillus paracasei ssp. paracasei, L. casei 431® in an influenza vaccination model: a randomised, double-blind, placebo-controlled study.
Rizzardini G; Eskesen D; Calder PC; Capetti A; Jespersen L; Clerici M
Br J Nutr; 2012 Mar; 107(6):876-84. PubMed ID: 21899798
[TBL] [Abstract][Full Text] [Related]
7. Impact of Bifidobacterium animalis subsp. lactis BB-12 and, Lactobacillus acidophilus LA-5-containing yoghurt, on fecal bacterial counts of healthy adults.
Savard P; Lamarche B; Paradis ME; Thiboutot H; Laurin É; Roy D
Int J Food Microbiol; 2011 Sep; 149(1):50-7. PubMed ID: 21296446
[TBL] [Abstract][Full Text] [Related]
8. Effect of Lactobacillus gasseri PA 16/8, Bifidobacterium longum SP 07/3, B. bifidum MF 20/5 on common cold episodes: a double blind, randomized, controlled trial.
de Vrese M; Winkler P; Rautenberg P; Harder T; Noah C; Laue C; Ott S; Hampe J; Schreiber S; Heller K; Schrezenmeir J
Clin Nutr; 2005 Aug; 24(4):481-91. PubMed ID: 16054520
[TBL] [Abstract][Full Text] [Related]
9. Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults.
Olivares M; Díaz-Ropero MA; Gómez N; Lara-Villoslada F; Sierra S; Maldonado JA; Martín R; López-Huertas E; Rodríguez JM; Xaus J
Int J Food Microbiol; 2006 Mar; 107(2):104-11. PubMed ID: 16271414
[TBL] [Abstract][Full Text] [Related]
10. Tetracycline susceptibility of the ingested Lactobacillus acidophilus LaCH-5 and Bifidobacterium animalis subsp. lactis Bb-12 strains during antibiotic/probiotic intervention.
Saarela M; Maukonen J; von Wright A; Vilpponen-Salmela T; Patterson AJ; Scott KP; Hämynen H; Mättö J
Int J Antimicrob Agents; 2007 Mar; 29(3):271-80. PubMed ID: 17207972
[TBL] [Abstract][Full Text] [Related]
11. Tolerance and safety of Lactobacillus paracasei ssp. paracasei in combination with Bifidobacterium animalis ssp. lactis in a prebiotic-containing infant formula: a randomised controlled trial.
Vlieger AM; Robroch A; van Buuren S; Kiers J; Rijkers G; Benninga MA; te Biesebeke R
Br J Nutr; 2009 Sep; 102(6):869-75. PubMed ID: 19331702
[TBL] [Abstract][Full Text] [Related]
12. The effect of a multispecies probiotic mixture on the symptoms and fecal microbiota in diarrhea-dominant irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial.
Ki Cha B; Mun Jung S; Hwan Choi C; Song ID; Woong Lee H; Joon Kim H; Hyuk J; Kyung Chang S; Kim K; Chung WS; Seo JG
J Clin Gastroenterol; 2012 Mar; 46(3):220-7. PubMed ID: 22157240
[TBL] [Abstract][Full Text] [Related]
13. The effect of probiotics on faecal microbiota and genotoxic activity of faecal water in patients with atopic dermatitis: a randomized, placebo-controlled study.
Roessler A; Forssten SD; Glei M; Ouwehand AC; Jahreis G
Clin Nutr; 2012 Feb; 31(1):22-9. PubMed ID: 21963389
[TBL] [Abstract][Full Text] [Related]
14. Safety of Bifidobacterium animalis subsp. lactis (B. lactis) strain BB-12-supplemented yogurt in healthy adults on antibiotics: a phase I safety study.
Merenstein DJ; Tan TP; Molokin A; Smith KH; Roberts RF; Shara NM; Mete M; Sanders ME; Solano-Aguilar G
Gut Microbes; 2015; 6(1):66-77. PubMed ID: 25569274
[TBL] [Abstract][Full Text] [Related]
15. Effect of the probiotic strain Bifidobacterium animalis subsp. lactis, BB-12®, on defecation frequency in healthy subjects with low defecation frequency and abdominal discomfort: a randomised, double-blind, placebo-controlled, parallel-group trial.
Eskesen D; Jespersen L; Michelsen B; Whorwell PJ; Müller-Lissner S; Morberg CM
Br J Nutr; 2015 Nov; 114(10):1638-46. PubMed ID: 26382580
[TBL] [Abstract][Full Text] [Related]
16. Lactulose ingestion increases faecal bifidobacterial counts: a randomised double-blind study in healthy humans.
Bouhnik Y; Attar A; Joly FA; Riottot M; Dyard F; Flourié B
Eur J Clin Nutr; 2004 Mar; 58(3):462-6. PubMed ID: 14985684
[TBL] [Abstract][Full Text] [Related]
17. Microbiological effects of consuming a synbiotic containing Bifidobacterium bifidum, Bifidobacterium lactis, and oligofructose in elderly persons, determined by real-time polymerase chain reaction and counting of viable bacteria.
Bartosch S; Woodmansey EJ; Paterson JC; McMurdo ME; Macfarlane GT
Clin Infect Dis; 2005 Jan; 40(1):28-37. PubMed ID: 15614689
[TBL] [Abstract][Full Text] [Related]
18. Dynamics of fecal microbiota in hospitalized elderly fed probiotic LKM512 yogurt.
Matsumoto M; Sakamoto M; Benno Y
Microbiol Immunol; 2009 Aug; 53(8):421-32. PubMed ID: 19659926
[TBL] [Abstract][Full Text] [Related]
19. Bifidobacterium animalis subsp. lactis BB-12 in reducing the risk of infections in infancy.
Taipale T; Pienihäkkinen K; Isolauri E; Larsen C; Brockmann E; Alanen P; Jokela J; Söderling E
Br J Nutr; 2011 Feb; 105(3):409-16. PubMed ID: 20863419
[TBL] [Abstract][Full Text] [Related]
20. Effects of synbiotic fermented milk containing Lactobacillus acidophilus La-5 and Bifidobacterium animalis ssp. lactis BB-12 on the fecal microbiota of adults with irritable bowel syndrome: A randomized double-blind, placebo-controlled trial.
Bogovič Matijašić B; Obermajer T; Lipoglavšek L; Sernel T; Locatelli I; Kos M; Šmid A; Rogelj I
J Dairy Sci; 2016 Jul; 99(7):5008-5021. PubMed ID: 27157575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
